All Pharma News
Coherus to Report Second Quarter 2024 Financial Results on August 8, 2024

Coherus to Report Second Quarter 2024 Financial Results on August 8, 2024
GLOBENEWSWIRE
01 Aug 2024
Share Share
Coherus BioSciences Announces Divestiture of YUSIMRY (adalimumab-aqvh)

Coherus BioSciences Announces Divestiture of YUSIMRY (adalimumab-aqvh)
GLOBENEWSWIRE
27 Jun 2024
Share Share
What Coherus` $40M sale of its Humira biosimilar says about the crowded market

What Coherus` $40M sale of its Humira biosimilar says about the crowded market
ENDPOINTS
27 Jun 2024
Share Share
Junshi, Coherus move Loqtorzi closer to another approval

Junshi, Coherus move Loqtorzi closer to another approval
Kevin Dunleavy FIERCE PHARMA
13 Jun 2024
Share Share
Coherus BioSciences Appoints Rita Karachun, CPA, CGMA to its Board of Directors

Coherus BioSciences Appoints Rita Karachun, CPA, CGMA to its Board of Directors
GLOBENEWSWIRE
05 Jun 2024
Share Share
Coherus Management to Present at the 2024 Jefferies Global Healthcare Conference

Coherus Management to Present at the 2024 Jefferies Global Healthcare Conference
GLOBENEWSWIRE
30 May 2024
Share Share
Coherus Oncology Summit Presence: Cowen Insights Asco Eha Featured

Coherus Oncology Summit Presence: Cowen Insights Asco Eha Featured
GLOBENEWSWIRE
23 May 2024
Share Share
Coherus Phase I Anti-Ccr8: Chs-114 Preliminary At 2024 Asco

Coherus Phase I Anti-Ccr8: Chs-114 Preliminary At 2024 Asco
GLOBENEWSWIRE
23 May 2024
Share Share
Coherus Announces Full Repayment of Pharmakon Advisors $75 Million Term Loan

Coherus Announces Full Repayment of Pharmakon Advisors $75 Million Term Loan
GLOBENEWSWIRE
09 May 2024
Share Share
Coherus BioSciences Q1 2024 Financials And Business Update

Coherus BioSciences Q1 2024 Financials And Business Update
GLOBENEWSWIRE
09 May 2024
Share Share